GLEN.L vs. AMPH
GLEN.L (Glencore plc) and AMPH (Amphastar Pharmaceuticals, Inc.) are both stocks. GLEN.L operates in Other Industrial Metals & Mining (Basic Materials), while AMPH operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, GLEN.L returned 20.95%/yr vs 3.00%/yr for AMPH. At a 0.06 correlation, their price movements are largely independent.
Performance
GLEN.L vs. AMPH - Performance Comparison
Loading charts...
Different Trading Currencies
GLEN.L is traded in GBp, while AMPH is traded in USD. To make them comparable, the AMPH values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, GLEN.L achieves a 46.47% return, which is significantly higher than AMPH's -24.60% return. Over the past 10 years, GLEN.L has outperformed AMPH with an annualized return of 20.95%, while AMPH has yielded a comparatively lower 3.00% annualized return.
GLEN.L
- 1D
- 2.56%
- 1M
- -1.17%
- YTD
- 46.47%
- 6M
- 58.58%
- 1Y
- 106.77%
- 3Y*
- 12.95%
- 5Y*
- 17.95%
- 10Y*
- 20.95%
AMPH
- 1D
- -2.06%
- 1M
- 16.10%
- YTD
- -24.60%
- 6M
- -20.70%
- 1Y
- -21.22%
- 3Y*
- -26.24%
- 5Y*
- 1.21%
- 10Y*
- 3.00%
GLEN.L vs. AMPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GLEN.L Glencore plc | 46.47% | 18.34% | -23.37% | -6.11% | 57.13% | 66.99% | -1.00% | -14.47% | -21.89% | 42.98% |
AMPH Amphastar Pharmaceuticals, Inc. | -24.60% | -33.01% | -38.92% | 109.70% | 34.61% | 16.91% | 1.19% | -6.75% | 9.56% | -4.58% |
Correlation
The correlation between GLEN.L and AMPH is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2014 | 0.06 |
Fundamentals
GLEN.L:
£71.06B
AMPH:
$933.34M
GLEN.L:
-$0.10
AMPH:
$1.67
GLEN.L:
0.20
AMPH:
1.32
GLEN.L:
2.45
AMPH:
1.21
GLEN.L:
$479.07B
AMPH:
$720.53M
GLEN.L:
$11.90B
AMPH:
$341.13M
GLEN.L:
$19.53B
AMPH:
$155.96M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLEN.L vs. AMPH — Risk / Return Rank
GLEN.L
AMPH
GLEN.L vs. AMPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Glencore plc (GLEN.L) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLEN.L | AMPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.89 | ||
| Sortino ratioReturn per unit of downside risk | +4.49 | ||
| Omega ratioGain probability vs. loss probability | 1.54 | 0.96 | +0.58 |
| Calmar ratioReturn relative to maximum drawdown | 7.74 | -0.51 | +8.25 |
| Martin ratioReturn relative to average drawdown | 24.83 | -1.02 | +25.85 |
Loading charts...
Drawdowns
GLEN.L vs. AMPH - Drawdown Comparison
The maximum GLEN.L drawdown since its inception was -87.37%, which is greater than AMPH's maximum drawdown of -75.17%. Use the drawdown chart below to compare losses from any high point for GLEN.L and AMPH.
Loading charts...
Drawdown Indicators
| GLEN.L | AMPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.37% | -75.17% | -12.20% |
Max Drawdown (1Y)Largest decline over 1 year | -14.09% | -44.95% | +30.86% |
Max Drawdown (3Y)Largest decline over 3 years | -53.56% | -75.17% | +21.61% |
Max Drawdown (5Y)Largest decline over 5 years | -55.24% | -75.17% | +19.93% |
Max Drawdown (10Y)Largest decline over 10 years | -69.99% | -75.17% | +5.18% |
Current DrawdownCurrent decline from peak | -4.24% | -70.61% | +66.37% |
Average DrawdownAverage peak-to-trough decline | -36.33% | -23.93% | -12.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.40% | 22.52% | -18.12% |
Volatility
GLEN.L vs. AMPH - Volatility Comparison
The current volatility for Glencore plc (GLEN.L) is 10.71%, while Amphastar Pharmaceuticals, Inc. (AMPH) has a volatility of 11.71%. This indicates that GLEN.L experiences smaller price fluctuations and is considered to be less risky than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLEN.L | AMPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.71% | 11.71% | -1.00% |
Volatility (6M)Calculated over the trailing 6-month period | 22.78% | 46.08% | -23.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.50% | 53.46% | -21.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.32% | 45.25% | -12.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.56% | 43.26% | -7.70% |
Dividends
GLEN.L vs. AMPH - Dividend Comparison
GLEN.L's dividend yield for the trailing twelve months is around 1.70%, while AMPH has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GLEN.L Glencore plc | 1.70% | 1.84% | 2.87% | 8.72% | 5.58% | 3.08% | 0.00% | 6.70% | 5.16% | 1.37% |
Financials
GLEN.L vs. AMPH - Financials Comparison
This section allows you to compare key financial metrics between Glencore plc and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GLEN.L vs. AMPH - Profitability Comparison
GLEN.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Glencore plc reported a gross profit of 3.44B and revenue of 130.73B. Therefore, the gross margin over that period was 2.6%.
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 70.32M and revenue of 171.17M. Therefore, the gross margin over that period was 41.1%.
GLEN.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Glencore plc reported an operating income of 2.18B and revenue of 130.73B, resulting in an operating margin of 1.7%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 13.63M and revenue of 171.17M, resulting in an operating margin of 8.0%.
GLEN.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Glencore plc reported a net income of 1.02B and revenue of 130.73B, resulting in a net margin of 0.8%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 6.42M and revenue of 171.17M, resulting in a net margin of 3.8%.
Frequently Asked Questions
GLEN.L and AMPH have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GLEN.L and AMPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer